Strategic Advice
ORION has worked in a wide variety of therapeutic areas and we have assisted our clients by providing strategic advice on many aspects of their drug development programmes. This has included:
- Advice on regulatory strategy
- Orphan drug designation
- Selection of the best countries in which to conduct a clinical development programme
- Clinical study design
- Obtaining advice from both EMEA and FDA
- Organising clinical expert groups
Strategic advice is provided by in-house personnel supplemented by our network of external consultants as appropriate.